Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Rating of “Hold” from Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned a consensus rating of “Hold” from the fifteen research firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $28.6923.

A number of analysts have commented on the stock. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a report on Monday, May 4th. KeyCorp boosted their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. TD Cowen upped their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. UBS Group raised their target price on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Finally, Guggenheim lifted their target price on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th.

Acadia Healthcare Trading Up 1.5%

Acadia Healthcare stock opened at $34.51 on Friday. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $35.83. The company has a market cap of $3.17 billion, a P/E ratio of -2.82, a P/E/G ratio of 11.34 and a beta of 0.64. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The business has a 50-day simple moving average of $27.64 and a two-hundred day simple moving average of $23.18.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Analysts predict that Acadia Healthcare will post 1.5 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC grew its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the period. Wells Fargo & Company MN raised its stake in Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares during the period. Bayforest Capital Ltd purchased a new position in Acadia Healthcare during the fourth quarter valued at approximately $52,000. GAMMA Investing LLC boosted its position in shares of Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its position in shares of Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.